Treating patients with a drug before surgery greatly reduced the chances of the cancer coming back, a small trial found.

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

"MHRA approves AstraZeneca’s Trixeo Aerosphere inhaler for COPD" was originally created and published by Pharmaceutical ...

AstraZeneca's Breztri Aerosphere in India is made using a new type of gas (called a next-generation propellant) that does not ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to researchers. In a trial where cancers were treated with chemotherapy ...

The president claimed his “most-favored nation” proposal would reduce some pharmaceutical prices by as much as 80%, but the ...

By Sandra Agyeiwaa OTOOTrust Specialists Hospital, in partnership with AstraZeneca, has marked World Asthma Day 2025 with a ...

President Donald Trump’s move to revive a policy that would slash Americans’ drug costs by tying them to lower prices paid ...